Cargando…
EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low
PURPOSE: The potential utility of circulating tumor cells (CTCs) as liquid biopsies is of great interest. We hypothesized that CTC capture using EpCAM based gating is feasible for most breast cancer subtypes. RESULTS: Cancer cells could be recovered from all intrinsic subtypes of breast cancer with...
Autores principales: | Ring, Alexander, Mineyev, Neal, Zhu, Weizhu, Park, Emily, Lomas, Chip, Punj, Vasu, Yu, Min, Barrak, Dany, Forte, Victoria, Porras, Tania, Tripathy, Debu, Lang, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792580/ https://www.ncbi.nlm.nih.gov/pubmed/26556851 |
Ejemplares similares
-
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
EpCAM-claudin-tetraspanin-modulated ovarian cancer progression and drug resistance
por: Tavsan, Zehra, et al.
Publicado: (2020) -
Clipping EpCAM to release Claudin-7 for the greater good of the epithelial barrier
por: Varadarajan, Saranyaraajan, et al.
Publicado: (2022) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma
por: Okada, Toshihiro, et al.
Publicado: (2014)